NYSE · LLY
Eli Lilly and Company
$1,417.62+$43.92 (+3.2%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.21% below the high.
Loading market information…
CNQ · CBDN.CN · CAD
Stock price, earnings
Quote as of Jul 6, 2022, 06:19 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.88% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CBD Global Sciences Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CBD Global Sciences Inc. operates across the entire spectrum of cannabidiol (CBD) activities, from cultivating the plant to processing it and ultimately manufacturing finished CBD products. The company provides a range of items, including raw CBD biomass, refined CBD oil, and various consumer products containing CBD oil, all distributed under its proprietary brands: Aethics, CannaOil, and Strasburg Pharms. Established in 2018, the firm maintains its primary business operations in Lakewood, Colorado.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:08 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,417.62+$43.92 (+3.2%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.21% below the high.
$274.61-$0.59 (-0.21%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.62% below the high.
$294.45+$3.66 (+1.26%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.44% below the high.
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
CA$0.05CA$0.00 (0.0%)
Craftport Cannabis Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.03CA$0.00 (0.0%)
Poko Innovations Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
West Island Brands Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Fiore Cannabis Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
